Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Novus TherapeuticsAcura PharmaceuticalsRexahn PharmaceuticalsTonix PharmaceuticalsTetraphase Pharmaceuticals
SymbolNASDAQ:NVUSOTCMKTS:ACURNASDAQ:REXNNASDAQ:TNXPNASDAQ:TTPH
Price Information
Current Price$0.52$0.33$2.90$0.43$2.26
52 Week RangeBuyN/AHoldBuyHold
Analyst Ratings
Consensus RecommendationBuyN/AHoldBuyHold
Consensus Price Target$6.00N/A$23.00$1.30$57.00
% Upside from Price Target1,053.85% upsideN/A693.10% upside205.52% upside2,422.12% upside
Trade Information
Market Cap$6.64 million$6.50 million$11.05 million$3.84 million$7.87 million
Beta2.841.481.211.082.4
Average Volume399,6836,1521,237,4372,503,661186,367
Sales & Book Value
Annual RevenueN/A$410,000.00N/AN/A$18.90 million
Price / SalesN/A17.16N/AN/A0.41
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.54 per share($0.17) per share$2.63 per share$72.79 per share$29.72 per share
Price / BookN/A-1.91N/AN/A0.08
Profitability
Net Income$-14,060,000.00$-3,840,000.00$-14,370,000.00$-26,090,000.00$-72,160,000.00
EPS($1.56)N/A($5.28)($268.10)($27.40)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/A∞N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,094.78%N/AN/A-804.43%
Return on Equity (ROE)-122.39%N/A-76.20%-171.46%-152.06%
Return on Assets (ROA)-103.06%-118.59%-58.03%-149.41%-87.96%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/A0.01%0.01%0.14%
Current Ratio7.40%0.56%4.88%4.88%2.70%
Quick Ratio7.40%0.56%4.88%4.88%2.49%
Ownership Information
Institutional Ownership Percentage42.71%N/A5.16%6.25%15.91%
Insider Ownership Percentage5.70%5.60%1.10%0.40%5.70%
Miscellaneous
EmployeesN/A141012119
Shares Outstanding12.97 million21.65 million4.02 million8.50 million3.47 million
Next Earnings Date3/26/2020 (Estimated)10/6/2020 (Estimated)3/13/2020 (Estimated)3/16/2020 (Estimated)3/12/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel